SCHEMBL23844159

SCHEMBL23844159

COC(F)(COCN[C@@H](C)C(=O)O[C@@H]1CCN(C)C1)[C@@H](OC(=O)C(C)C)[C@@H](OC(=O)C(C)C)c1ccc2c(N)ncnn12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26340518 0.90 — —
SCHEMBL26340411 0.90 — —
SCHEMBL23819154 0.86 — —
SCHEMBL23844054 0.84 RIPK1 (0.30) —
SCHEMBL23819009 0.81 RIPK1 (0.30) —
SCHEMBL26333188 0.79 — —
SCHEMBL26333090 0.79 — —
SCHEMBL26333805 0.78 EGLN2 (0.31) —
SCHEMBL26333790 0.78 EGLN2 (0.31) —
SCHEMBL26340470 0.78 BTN3A1 (0.32) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210292348-A1 ANTIVIRAL COMPOUNDS GILEAD SCIENCES, INC. 2021-09-23 — — US disclosed
Send feedback